Fubi Luofen Pian (氟比洛芬片)氟比洛芬片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司
药物知识说明
是氟比洛芬是一种在国家药监局注册认定的药品。标注生产企业为上海中西三维药业有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司、上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司、上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氟比洛芬片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 上海中西三维药业有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司, 上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司, 上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氟比洛芬片Recorded Chinese name: 氟比洛芬片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 50mg50 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 上海中西三维药业有限公司Chinese legal name: 上海中西三维药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19980112
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19980112
Manufacturer
Chinese legal name: 上海中西三维药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H19980112
生产企业
上海中西三维药业有限公司(国产)
适应症
1.适用于类风湿关节炎、骨关节炎、强直性脊柱炎等。 2.也可用于软组织病（如扭伤及劳损）以及轻中度疼痛（如痛经和手术后疼痛、牙痛等）的对症治疗。
用法用量
成人常用量：口服，一次50mg(1片)，一日3～4次，必要时可增加剂量，但每日最大剂量不超过300mg（6片），或遵医嘱。
不良反应
1.较常见的不良反应是消化道反应，如消化不良、腹泻、腹痛、恶心、便秘、胃肠道出血、腹胀、呕吐、血清转氨酶升高等。
2.偶见中枢神经系统反应，如头痛、嗜睡等，以及其他系统反应，如皮疹、视力变化、头晕等。
禁忌
1.对本品或其他非甾体抗炎药过敏者。
2.活动期消化性溃疡患者禁用。
注意事项
1.有胃肠道溃疡病史者慎用。
2.有支气管哮喘病史患者或因服用其它非甾体抗炎药曾发生支气管痉挛的患者应慎用。
3.心、肝、肾功能不全及高血压、血友病患者慎用。
4.长期用药时应定期检查血象及肝、肾功能。
5.据报道，本品可引起视力变化，故有内眼病的患者应慎用。
6.本品可以抑制血小板凝集，延长出血时间，故出血时间延长的患者应慎用。
贮藏
遮光，密封保存。
规格
50mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.